Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viz.ai
MedTech
Viz.ai nets FDA OK for app to spot hypertrophic cardiomyopathy
Viz.ai has received a green light from the FDA for its AI software that sifts through ECGs to spot signs of a thickened or enlarged heart muscle.
Conor Hale
Aug 7, 2023 10:22am
FDA clears Viz.ai's abdominal aortic aneurysm-spotting AI
Mar 21, 2023 10:12am
Fierce Medtech's 2022 Fierce 15
Mar 20, 2023 3:00am
BMS backs Viz.ai's latest AI-powered diagnostic tool
Mar 3, 2023 10:00am
JPM23: What's medtech's place at the conference? CEOs weigh in
Jan 12, 2023 9:45am
JPM23's Medtech Tidbits: Reporting from San Francisco
Jan 11, 2023 11:11am
